Phibro Animal Health (PAHC) Misses Q3 EPS by 5c; Trims FY16 Outlook
Phibro Animal Health (NASDAQ: PAHC) reported Q3 EPS of $0.38, $0.05 worse than the analyst estimate of $0.43. Revenue for the quarter came in at $183 million versus the consensus estimate of $197.24 million.
GUIDANCE:
Phibro Animal Health sees FY2016 EPS of $1.58-$1.60, versus the consensus of $1.70. Phibro Animal Health sees FY2016 revenue of $745-750 million, versus the consensus of $775.0 million.
For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.
